[1]
Jabin, M. et al. 2023. Efficacy of Daclatasvir and Half Dose Sofosbuvir in the Treatment of Hepatitis –C Virus Infection in Patients of Maintanance Hemodialysis-3 Years Trial in A Tertiary Renal Center. Journal of Bangladesh College of Physicians and Surgeons. 41, 2 (Mar. 2023), 102–107. DOI:https://doi.org/10.3329/jbcps.v41i2.64539.